Tanemura, Nanae http://orcid.org/0000-0002-1787-9571
Sasaki, Tsuyoshi http://orcid.org/0000-0001-8502-6469
Sato, Junko
Urushihara, Hisashi http://orcid.org/0000-0001-6913-9930
Funding for this research was provided by:
Research Foundation for Pharmaceutical Sciences
Pfizer Health Research Foundation
Article History
First Online: 29 July 2020
Compliance with ethical standards
:
: This research received two specific grants, from the Research Foundation for Pharmaceutical Sciences in 2019 and the Pfizer Health Research Foundation in 2018.
: Tsuyoshi Sasaki has received speakers’ honoraria from Daiichi Sankyo, Eli Lilly, GlaxoSmithKline, Novartis, Janssen, Otsuka, Shionogi, Shire, Takeda, Taisho, and Tanabe Mitsubishi, and has also received research support from Novartis, Otsuka, Shionogi, and Taisho (from April 2014 to December 2019). Hisashi Urushihara has received a research grant from Shionogi and Senju Pharmaceutical Corporation, and has also received research funds from Daiichi Sankyo, Tanabe Mitsubishi, and Astellas. Nanae Tanemura and Junko Sato declare no potential conflicts of interest regarding the research, authorship, and/or publication of this article.
: This survey was approved by the Keio University Faculty of Pharmacy’s Ethics Committee for Research Involving Humans on 18 March 2019 (No. 190318–1). The study was conducted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its subsequent amendments.
: We posted the general outline of our research at the top of the survey website for the nominated subjects. We considered participants completing the survey as providing consent in accordance with the <i>Ethical Guidelines for Medical and Health Research Involving Human Subjects</i> published by the Ministry of Health, Labor, and Welfare in Japan.
: Not applicable.
: All relevant data are included within the paper and its supporting information files.
: Not applicable.